The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mirabelli Christopher since year 2005.
The trader's CIK number is 1262326.
At the time of this reporting, Mirabelli Christopher is the CEO, President, Chairman of Leap Therapeutics, Inc. .
(stock ticker symbol LPTX).
See this page for all insider trading activities at Leap Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-02-05||LPTX||Leap Therapeutics, Inc.||Buy||571,428||1.75||999,999|
|2017-11-14||LPTX||Leap Therapeutics, Inc.||Buy||1,057,769||6.08||6,436,524|
|2005-06-20||CRTX||Critical Therapeutics Inc||Buy||1,094,891||5.48||6,000,002|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mirabelli Christopher (CEO, President, Chairman of Leap Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.